GIM
AGN

Gyrus Investment Management’s Allergan Inc AGN Stock Holding History

Gyrus Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-21,024
Closed -$4.47M – 113
2014
Q4 		$4.47M Sell
21,024
-605
-3% -$120K 0.74% 58
2014
Q3 		$3.85M Sell
21,629
-375
-2% -$62.3K 0.68% 61
2014
Q2 		$3.72M Sell
22,004
-5,150
-19% -$802K 0.67% 64
2014
Q1 		$3.72M Buy
+27,154
New +$3.31M 0.64% 68
2013
Q4 		– Sell
-22,679
Closed -$2.11M – 113
2013
Q3 		$2.11M Sell
22,679
-78
-0.3% -$7K 0.46% 78
2013
Q2 		$2.02M Buy
+22,757
New +$2.36M 0.46% 76

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Gyrus Investment Management's AGN Position: Q1 2015 in Review

Gyrus Investment Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 21,024 shares — an estimated $4.47M sold.

Gyrus Investment Management first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $4.47M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Gyrus Investment Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Gyrus Investment Management sold 21,024 Allergan Inc shares in Q1 2015, an estimated $4.47M.
  • Gyrus Investment Management first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Gyrus Investment Management's Allergan Inc position peaked at $4.47M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Gyrus Investment Management's 13F filing for Q1 2015, filed 14 May 2015.